All posts
-
Honda is exploring steering-assist crash avoidance for motorcycles
Honda’s brand-new license asks one strange yet extremely fascinating inquiry: what happens if motorbikes came outfitted with a steering-assist system, which would certainly a…
-
Novo Nordisk ranks among the biggest European losers in 2025
The Danish pharmaceutical firm rates 6th amongst the supplies that have actually done worst in the European Stoxx 600 index this year.
-
Analysis boss downplays Demant’s concerns about increased competition in the US
Competitors for United States customers is escalating for Danish listening devices titans complying with a tender from grocery store chain Costco. This must not be a reason for sig…
-
Eli Lilly follows Novo Nordisk and cuts prices on weight loss drugs in China
On Monday, Novo Nordisk validated that the firm is readjusting rates in chosen areas in China.
-
Life science executives have learned an important lesson after a year of Trump chaos
The profession battle and unpredictabilities in the United States over the previous year have actually made it essential to remain on track and not be sidetracked by changability, …
-
Genmab drops development of important cancer candidate
Genmab’s chief executive officer has actually consistently highlighted cancer cells medicine prospect acasunlimab as a significant sales intend to load the profits void at th…
-
U-turn in US health insurance gives Coloplast a “dull Christmas present”
Wellness authorities in the United States have actually rescinded a current choice that provided 2 of Coloplast’s injury treatment items unique condition with United States h…
-
Ahead of patent expiry: Novo Nordisk lowers the price of Wegovy in China
Novo Nordisk’s semaglutide, the energetic component in Wegovy, runs out in China in March 2026.
-
3 roles every marketing leader needs now
Martech underperforms when abilities hang back devices. These 3 duties transform innovation financial investment right into actual service effect.The article 3 duties every adverti…
-
Biobeat Secures $50 Million Series B Financing to Advance Commercialization of its Patch-worn, Cuff-less 24-hour Ambulatory Blood Pressure Monitor
PETAH TIKVA, Israel & BOCA RATON, Fla.–(ORGANIZATION CORD)– # 24hourABPM– Biobeat shut a $50M Collection B, led by Ally Bridge, OrbiMed, and Elevage, to incr…
